Six-month antibody persistence after BNT162b2 mRNA COVID-19 vaccination in patients with chronic lymphocytic leukemia
[Display omitted]
Gespeichert in:
| Veröffentlicht in: | Blood advances 2022-01, Vol.6 (1), p.148-151 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 151 |
|---|---|
| container_issue | 1 |
| container_start_page | 148 |
| container_title | Blood advances |
| container_volume | 6 |
| creator | Herishanu, Yair Avivi, Irit Levi, Shai Shefer, Gabi Bronstein, Yotam Moshiashvili, Miguel Morales Ziv, Tomer Scarfò, Lydia Perry, Chava Ghia, Paolo |
| description | [Display omitted] |
| doi_str_mv | 10.1182/bloodadvances.2021005998 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8500836</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2473952921007035</els_id><sourcerecordid>2580018771</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-68ccdd1038bbd6d1b33df14373c394feb21bf044d88ec1e2f521a75bc665d2be3</originalsourceid><addsrcrecordid>eNqFkctuFDEQRS0EIlHILyAv2XTwox_uDVIyhBApSiQIbC0_qhlDt93Y7oH5-3g0YSArVnWlunWrVAchTMkZpYK91WMIVtmN8gbSGSOMEtL0vXiGjlnd8apvePf8oFl_hE5T-k4IoV3Lm569REe8bmndUH6Mls_udzUFn9dY-ex0sFs8Q0wuZSj5WA0ZIr64vact0wxPn27P8eru6_X7ivZ4o4xxXmUXPHYez0WBzwn_ciXOrGPwzuBxO83rYLZ5p2H5AZNTr9CLQY0JTh_rCfry4fJ-9bG6ubu6Xp3fVKYmfa5aYYy1lHChtW0t1Zzbgda844b39QCaUT2QurZCgKHAhoZR1TXatG1jmQZ-gt7tc-dFT2BNuS6qUc7RTSpuZVBOPu14t5bfwkaKhhDB2xLw5jEghp8LpCwnlwyMo_IQliRZI8pfRdfRYhV7q4khpQjDYQ0lcgdOPgEn_4Iro6__PfMw-AdTMVzsDVCetXEQZTJux8e6CCZLG9z_tzwA8FexbQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2580018771</pqid></control><display><type>article</type><title>Six-month antibody persistence after BNT162b2 mRNA COVID-19 vaccination in patients with chronic lymphocytic leukemia</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Herishanu, Yair ; Avivi, Irit ; Levi, Shai ; Shefer, Gabi ; Bronstein, Yotam ; Moshiashvili, Miguel Morales ; Ziv, Tomer ; Scarfò, Lydia ; Perry, Chava ; Ghia, Paolo</creator><creatorcontrib>Herishanu, Yair ; Avivi, Irit ; Levi, Shai ; Shefer, Gabi ; Bronstein, Yotam ; Moshiashvili, Miguel Morales ; Ziv, Tomer ; Scarfò, Lydia ; Perry, Chava ; Ghia, Paolo</creatorcontrib><description>[Display omitted]</description><identifier>ISSN: 2473-9529</identifier><identifier>EISSN: 2473-9537</identifier><identifier>DOI: 10.1182/bloodadvances.2021005998</identifier><identifier>PMID: 34614513</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Antibodies, Viral ; BNT162 Vaccine ; COVID-19 ; COVID-19 Vaccines ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell - genetics ; Research Letter ; RNA, Messenger - genetics ; SARS-CoV-2 ; Vaccination</subject><ispartof>Blood advances, 2022-01, Vol.6 (1), p.148-151</ispartof><rights>2022 The American Society of Hematology</rights><rights>2022 by The American Society of Hematology. Licensed under , permitting only noncommercial, nonderivative use with attribution. All other rights reserved. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-68ccdd1038bbd6d1b33df14373c394feb21bf044d88ec1e2f521a75bc665d2be3</citedby><cites>FETCH-LOGICAL-c409t-68ccdd1038bbd6d1b33df14373c394feb21bf044d88ec1e2f521a75bc665d2be3</cites><orcidid>0000-0002-1453-9029 ; 0000-0001-5763-9698 ; 0000-0002-2589-8473 ; 0000-0002-0844-0989 ; 0000-0003-3750-7342</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500836/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500836/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34614513$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Herishanu, Yair</creatorcontrib><creatorcontrib>Avivi, Irit</creatorcontrib><creatorcontrib>Levi, Shai</creatorcontrib><creatorcontrib>Shefer, Gabi</creatorcontrib><creatorcontrib>Bronstein, Yotam</creatorcontrib><creatorcontrib>Moshiashvili, Miguel Morales</creatorcontrib><creatorcontrib>Ziv, Tomer</creatorcontrib><creatorcontrib>Scarfò, Lydia</creatorcontrib><creatorcontrib>Perry, Chava</creatorcontrib><creatorcontrib>Ghia, Paolo</creatorcontrib><title>Six-month antibody persistence after BNT162b2 mRNA COVID-19 vaccination in patients with chronic lymphocytic leukemia</title><title>Blood advances</title><addtitle>Blood Adv</addtitle><description>[Display omitted]</description><subject>Antibodies, Viral</subject><subject>BNT162 Vaccine</subject><subject>COVID-19</subject><subject>COVID-19 Vaccines</subject><subject>Humans</subject><subject>Leukemia, Lymphocytic, Chronic, B-Cell - genetics</subject><subject>Research Letter</subject><subject>RNA, Messenger - genetics</subject><subject>SARS-CoV-2</subject><subject>Vaccination</subject><issn>2473-9529</issn><issn>2473-9537</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkctuFDEQRS0EIlHILyAv2XTwox_uDVIyhBApSiQIbC0_qhlDt93Y7oH5-3g0YSArVnWlunWrVAchTMkZpYK91WMIVtmN8gbSGSOMEtL0vXiGjlnd8apvePf8oFl_hE5T-k4IoV3Lm569REe8bmndUH6Mls_udzUFn9dY-ex0sFs8Q0wuZSj5WA0ZIr64vact0wxPn27P8eru6_X7ivZ4o4xxXmUXPHYez0WBzwn_ciXOrGPwzuBxO83rYLZ5p2H5AZNTr9CLQY0JTh_rCfry4fJ-9bG6ubu6Xp3fVKYmfa5aYYy1lHChtW0t1Zzbgda844b39QCaUT2QurZCgKHAhoZR1TXatG1jmQZ-gt7tc-dFT2BNuS6qUc7RTSpuZVBOPu14t5bfwkaKhhDB2xLw5jEghp8LpCwnlwyMo_IQliRZI8pfRdfRYhV7q4khpQjDYQ0lcgdOPgEn_4Iro6__PfMw-AdTMVzsDVCetXEQZTJux8e6CCZLG9z_tzwA8FexbQ</recordid><startdate>20220111</startdate><enddate>20220111</enddate><creator>Herishanu, Yair</creator><creator>Avivi, Irit</creator><creator>Levi, Shai</creator><creator>Shefer, Gabi</creator><creator>Bronstein, Yotam</creator><creator>Moshiashvili, Miguel Morales</creator><creator>Ziv, Tomer</creator><creator>Scarfò, Lydia</creator><creator>Perry, Chava</creator><creator>Ghia, Paolo</creator><general>Elsevier Inc</general><general>American Society of Hematology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1453-9029</orcidid><orcidid>https://orcid.org/0000-0001-5763-9698</orcidid><orcidid>https://orcid.org/0000-0002-2589-8473</orcidid><orcidid>https://orcid.org/0000-0002-0844-0989</orcidid><orcidid>https://orcid.org/0000-0003-3750-7342</orcidid></search><sort><creationdate>20220111</creationdate><title>Six-month antibody persistence after BNT162b2 mRNA COVID-19 vaccination in patients with chronic lymphocytic leukemia</title><author>Herishanu, Yair ; Avivi, Irit ; Levi, Shai ; Shefer, Gabi ; Bronstein, Yotam ; Moshiashvili, Miguel Morales ; Ziv, Tomer ; Scarfò, Lydia ; Perry, Chava ; Ghia, Paolo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-68ccdd1038bbd6d1b33df14373c394feb21bf044d88ec1e2f521a75bc665d2be3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antibodies, Viral</topic><topic>BNT162 Vaccine</topic><topic>COVID-19</topic><topic>COVID-19 Vaccines</topic><topic>Humans</topic><topic>Leukemia, Lymphocytic, Chronic, B-Cell - genetics</topic><topic>Research Letter</topic><topic>RNA, Messenger - genetics</topic><topic>SARS-CoV-2</topic><topic>Vaccination</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Herishanu, Yair</creatorcontrib><creatorcontrib>Avivi, Irit</creatorcontrib><creatorcontrib>Levi, Shai</creatorcontrib><creatorcontrib>Shefer, Gabi</creatorcontrib><creatorcontrib>Bronstein, Yotam</creatorcontrib><creatorcontrib>Moshiashvili, Miguel Morales</creatorcontrib><creatorcontrib>Ziv, Tomer</creatorcontrib><creatorcontrib>Scarfò, Lydia</creatorcontrib><creatorcontrib>Perry, Chava</creatorcontrib><creatorcontrib>Ghia, Paolo</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Blood advances</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Herishanu, Yair</au><au>Avivi, Irit</au><au>Levi, Shai</au><au>Shefer, Gabi</au><au>Bronstein, Yotam</au><au>Moshiashvili, Miguel Morales</au><au>Ziv, Tomer</au><au>Scarfò, Lydia</au><au>Perry, Chava</au><au>Ghia, Paolo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Six-month antibody persistence after BNT162b2 mRNA COVID-19 vaccination in patients with chronic lymphocytic leukemia</atitle><jtitle>Blood advances</jtitle><addtitle>Blood Adv</addtitle><date>2022-01-11</date><risdate>2022</risdate><volume>6</volume><issue>1</issue><spage>148</spage><epage>151</epage><pages>148-151</pages><issn>2473-9529</issn><eissn>2473-9537</eissn><abstract>[Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>34614513</pmid><doi>10.1182/bloodadvances.2021005998</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-1453-9029</orcidid><orcidid>https://orcid.org/0000-0001-5763-9698</orcidid><orcidid>https://orcid.org/0000-0002-2589-8473</orcidid><orcidid>https://orcid.org/0000-0002-0844-0989</orcidid><orcidid>https://orcid.org/0000-0003-3750-7342</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2473-9529 |
| ispartof | Blood advances, 2022-01, Vol.6 (1), p.148-151 |
| issn | 2473-9529 2473-9537 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8500836 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
| subjects | Antibodies, Viral BNT162 Vaccine COVID-19 COVID-19 Vaccines Humans Leukemia, Lymphocytic, Chronic, B-Cell - genetics Research Letter RNA, Messenger - genetics SARS-CoV-2 Vaccination |
| title | Six-month antibody persistence after BNT162b2 mRNA COVID-19 vaccination in patients with chronic lymphocytic leukemia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T03%3A39%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Six-month%20antibody%20persistence%20after%20BNT162b2%20mRNA%20COVID-19%20vaccination%20in%20patients%20with%20chronic%20lymphocytic%20leukemia&rft.jtitle=Blood%20advances&rft.au=Herishanu,%20Yair&rft.date=2022-01-11&rft.volume=6&rft.issue=1&rft.spage=148&rft.epage=151&rft.pages=148-151&rft.issn=2473-9529&rft.eissn=2473-9537&rft_id=info:doi/10.1182/bloodadvances.2021005998&rft_dat=%3Cproquest_pubme%3E2580018771%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2580018771&rft_id=info:pmid/34614513&rft_els_id=S2473952921007035&rfr_iscdi=true |